Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2011
08/03/2011EP2349267A1 Pyridazine carboxamide orexin receptor antagonists
08/03/2011EP2349266A1 Sulfonamide containing compounds and uses thereof
08/03/2011EP2349262A1 2,5-disubstituted phenyl carboxamide orexin receptor antagonists
08/03/2011EP2349256A1 Heterocyclic benzimidazoles as trpm8 modulators
08/03/2011EP2349246A1 Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, and epilepsy
08/03/2011EP2349244A1 Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof
08/03/2011EP2349238A1 Co-crystals of tramadol and nsaids
08/03/2011EP2349217A1 Novel composition based on gamma-hydroxybutyric acid
08/03/2011EP2348846A1 Disubstituted azepan orexin receptor antagonists
08/03/2011EP2240458B1 Aryl sulfonamides as effective analgesics
08/03/2011EP2211892B1 Compositions comprising myelin basic protein peptides and medical uses thereof
08/03/2011EP2200980B1 Amino arylsulfonamide compounds and their use as 5-ht6 ligands field of invention
08/03/2011EP2132185B1 Pyrimidinyl-piperazines useful as dopamine d3/d2 receptor ligands
08/03/2011EP2114970B1 Tricyclic compounds and their use as glucocorticoid receptor modulators
08/03/2011EP1976502B1 Small molecule inhibitors of pdz interactions
08/03/2011EP1846366B1 Norvaline derivative and method for preparation thereof
08/03/2011EP1836172B1 5-ht7 receptor antagonists
08/03/2011EP1794146B1 Tricyclic anilide spirohydantoin cgrp receptor antagonists
08/03/2011EP1534753B1 Peg positional isomer of an anti-tnfalpha antibody (cdp870)
08/03/2011EP1446104B2 Spray drying methods
08/03/2011EP1425272B1 Optical isomers of an iloperidone metabolite
08/03/2011EP1212055B1 Neurotherapeutic composition comprising a beta-lactam compound
08/03/2011CN1917862B Dosage form that is safeguarded from abuse
08/03/2011CN1784220B Use of effectors of glutaminyl and glutamate cyclases
08/03/2011CN1720238B Neurologically-active compounds
08/03/2011CN1700934B Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
08/03/2011CN102143965A Pyrazolopyrimidines and their use for the treatment of CNS disorders
08/03/2011CN102143963A Amides of diazabicyclooctanes and uses thereof
08/03/2011CN102143961A Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity
08/03/2011CN102143956A Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof
08/03/2011CN102143955A 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
08/03/2011CN102143951A Tri-substituted pyrimidine compounds and their use as PDE10 inhibitors
08/03/2011CN102143744A Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof
08/03/2011CN102140470A Human miR-1236 antisense ribonucleic acid and application thereof
08/03/2011CN102140469A Human miR (microRNA)-1233 antisensenucleic acid and application thereof
08/03/2011CN102140468A Human miR-185* antisense nucleic acid and application thereof
08/03/2011CN102140467A Human miR-365 antisense nucleic acid and application thereof
08/03/2011CN102140466A Human miR-1825 antisense nucleic acid and application thereof
08/03/2011CN102140465A Human miR-1249 antisense nucleic acid and application thereof
08/03/2011CN102140464A Human miR-1238 antisense nucleic acid and applications thereof
08/03/2011CN102140463A Human miR (microRNA)-1296 antisensenucleic acid and application thereof
08/03/2011CN102140462A Human miR-1260 antisense nucleic acid and application thereof
08/03/2011CN102140090A Dipeptidyl peptidase inhibitors
08/03/2011CN102140064A Compounds for the treatment of metabolic disorders
08/03/2011CN102139099A Therapeutic composition with a botulinum neurotoxin
08/03/2011CN102139094A Application of long-chain neurotoxin of cobra in preparation of muscarine type M4 receptor activator
08/03/2011CN102139093A Application of short-chain cobrotoxin in preparation of intrathecally administrated analgesic medicines
08/03/2011CN102139090A Chinese medicine composition for treating depression and preparation method and application thereof
08/03/2011CN102139086A Traditional Chinese medicine for treating liver constraint and spleen deficiency type post-stroke depression
08/03/2011CN102139076A Traditional Chinese medicine for treating diabetic foot
08/03/2011CN102139075A Traditional Chinese medicine for treating diabetic acral necrosis
08/03/2011CN102139066A Chinese medicinalal soft capsule
08/03/2011CN102139064A Chinese patent medicine for preventing and treating angioneurotic headache
08/03/2011CN102139056A Traditional Chinese medicine for treating diabetic peripheral neuropathy
08/03/2011CN102139048A Quality control method of tablet capable of improving eyesight and clearing heat
08/03/2011CN102139023A Health-care tobacco-control type Chinese medicinal herb sucking product and preparation method
08/03/2011CN102139020A Medicament for treating influenza and bad cold and preparation method thereof
08/03/2011CN102138982A Compound valeriana amurensis composition for treating senile dementia, and preparation method and application thereof
08/03/2011CN102138973A Quality control method for six-meridian headache tablets
08/03/2011CN102138972A Active Chinese herbal medicine preparation for preventing and treating senile dementia and dementia after cerebral infarction and preparation method thereof
08/03/2011CN102138967A Application of dracocephalum moldavica L. general flavone in preparing medicament for preventing and treating cerebrovascular disease
08/03/2011CN102138953A Application of chorispora bungeana or extract thereof in preparation of medicaments for preventing and treating cardiovascular and cerebrovascular diseases
08/03/2011CN102138952A Herbal grace osteophyte pain relieving spirits
08/03/2011CN102138945A Method of extracting active substances with high content of flavones from ginkgo leaves
08/03/2011CN102138937A Method for processing starfishes
08/03/2011CN102138926A Application of ginsenoside Rd to preparing anti-depression medicament
08/03/2011CN102138911A Divalproex sodium sustained release tablets and preparation method thereof
08/03/2011CN102138892A Choline alfoscerate injection preparation as well as preparation method and detection method thereof
08/03/2011CN102138747A Health-care medicament pillow for treating insomnia and preventing dementia
08/03/2011CN101766705B Medicinal combination containing borneol and musk
08/03/2011CN101766704B Medicinal combination containing borneol and musk
08/03/2011CN101766700B Medicinal combination containing musk
08/03/2011CN101766699B Medicinal combination containing musk
08/03/2011CN101642521B Medicine for treating cerebral apoplexy hemiplegy sequela
08/03/2011CN101624868B Wood floor and preparation method thereof
08/03/2011CN101468157B Chinese medicinal composition for treating insomnia and preparation method thereof
08/03/2011CN101307346B Method for extracting brain strengthening bioactive peptide from brain tissue of farming animals
08/03/2011CN101293055B Scutellaria health tea and its processing method
08/03/2011CN101273043B Pyrazolo[1,5-alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists
08/03/2011CN101160287B 吡啶基非芳香族含氮杂环-1-羧酸酯衍生物 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative
08/03/2011CN101095834B Decoction medicine for treating aypnia fantod type chronic bronchitis
08/02/2011US7989469 Certain chemical entities, compositions, and methods
08/02/2011US7989447 1,5 and 3,6-substituted indole compounds having NOS inhibitory activity
08/02/2011US7989444 Compounds having affinity for dopamine D3 receptor and uses thereof
08/02/2011US7989182 Nucleic acid encoding SCN1A variant
08/02/2011US7988997 Matrix of water soluble polymer; solidificated foam
08/02/2011US7988969 Treatment for central nervous system disorders
08/02/2011US7988956 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
08/02/2011US7988952 Condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns
08/02/2011CA2713292C Delayed release rasagiline formulation
08/02/2011CA2498735C Treatment of basal ganglia-related movement disorders with 2,3-benzodiazepines
08/02/2011CA2489723C Novel aryl-{4-halo-4-[heteroaryl-methylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments
08/02/2011CA2489209C New derivatives of arylsulfonamides and use thereof in therapy
08/02/2011CA2488242C Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
08/02/2011CA2479109C Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
08/02/2011CA2458025C Novel 4-aminofuropyrimidines and the use thereof
08/02/2011CA2449634C Somatostatin-dopamine chimeric analogs
08/02/2011CA2449298C A coated nicotine-containing chewing gum, manufacture and use thereof
08/02/2011CA2419420C Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
08/02/2011CA2419285C New uses for amino acid anticonvulsants